Once Daily Mometasone Furoate Aqueous Nasal Spray Is As Effective as Twice Daily Beclomethasone Dipropionate for Treating Perennial Allergic Rhinitis Patients
- 1 August 1996
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 77 (2), 153-160
- https://doi.org/10.1016/s1081-1206(10)63502-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- 62 Lack of systemic activity with intranasal mometasone furoateJournal of Allergy and Clinical Immunology, 1996
- Glucocorticosteroids and rhinitisAllergy, 1993
- Intranasal Fluticasone PropionateDrugs, 1992
- Topical Pharmacotherapy for Allergic RhinitisSouthern Medical Journal, 1992
- Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitisJournal of the American Academy of Dermatology, 1991
- Optimum Pharmacological Management of Chronic RhinitisDrugs, 1989
- Allergic and Nonallergic Rhinitis: Classification and Pathogenesis Part I. Allergic RhinitisAmerican Journal of Rhinology, 1989
- Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosolJournal of Allergy and Clinical Immunology, 1986
- Multicentric study of beclomethasone dipropionate nasal aerosol in adults with seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1982
- Beclomethasone dipropionate aerosol in perennial rhinitisJournal of Allergy and Clinical Immunology, 1977